There's a structural imbalance sitting at the center of healthcare revenue cycle that almost nobody talks about directly. Payers -- commercial insurers and Medicare Advantage plans especially -- have spent years and significant capital building automated adjudication systems that flag and deny claims at machine speed. The logic is deliberate: a denied claim that is never appealed is effectively free revenue. The math works for them because most hospitals don't have the operational infrastructure to appeal systematically, and because the volume of denials is simply overwhelming to work manually.
What providers are doing in response is largely reactive. A claim goes out. Days or weeks later, a denial comes back through the clearinghouse. A staff member -- already working a backlog of hundreds of accounts -- picks it up, researches the reason code, determines whether it's worth appealing, documents the appeal, submits it, and waits. McKinsey estimates this rework costs between $25 and $118 per denied claim. Across a health system processing thousands of claims weekly, that's a significant operational tax on revenue that was never really lost -- just delayed or abandoned.
$25-$118
Rework cost per denied claim (McKinsey)
60%
Of denials are never appealed
Milliseconds
Time for payer AI to deny a claim vs. days for provider response
The standard RCM workflow maps against the HFMA framework across three phases -- front end (pre-service), middle (point of service), and back end (post-service). Most of the AI tools on the market today live in the back end. By the time work reaches the back end, the clinical and documentation decisions that determined whether the claim was clean or not have already been made -- and cannot be undone efficiently.
Where the intelligence layer needs to live
The HFMA revenue cycle framework breaks into three phases. The front end covers pre-service work: eligibility and benefits verification, prior authorization, registration, and financial counseling. The middle phase is point of service: CDI and documentation, medical coding, utilization review, and charge capture. The back end handles post-service: claim submission, payment posting, denial management, and A/R follow-up.
The upstream intelligence layer -- the proactive part -- needs to span the front end and middle phases. That's where clinical decisions are made that determine downstream financial outcomes. Most tools today focus on the back end, which means they're reactive by definition. Meanwhile, clearinghouse and remittance data (claims, 835 ERA, CARC/RARC denial codes) should feed back into the intelligence layer continuously, creating the learning loop that makes the model better with every claim.
Reactive vs. proactive -- the operational difference
The reactive cycle (where most providers are today): A claim is filed based on available documentation with no payer-specific pre-check. The payer's auto-adjudication system reviews and denies it -- often in seconds. The denial is received and added to the queue at $25 to $118 in rework cost. Staff manually works the backlog, but 60% of denials are never appealed. Some revenue is recovered weeks later, but the root cause repeats on the next claim. The payer advantage is clear: payer AI denies in milliseconds while provider teams respond manually, days later, on a fraction of denied claims.
The proactive cycle (with upstream intelligence): Payer-specific risk is flagged at the point of care, before documentation is finalized. Coding and CDI guidance is surfaced in-workflow based on provider-specific patterns, not generic alerts. The claim is pre-checked against live payer rules with denial prediction before submission. Clean claims are submitted and paid on first pass, with a higher clean claim rate and lower cost to collect. Every outcome refines the model as clearinghouse data feeds back continuously. The provider advantage: AI learns your payer's denial patterns and CMS rules -- applied upstream with the same rigor payers use.
The reactive cycle ends in write-offs, A/R days, and FTE rework cost. The proactive cycle ends in a higher clean claim rate, lower write-offs, and faster cash. The difference is where the intelligence lives -- upstream or downstream.
Payers have industrialized denial. Providers need to industrialize the response.
A payer's adjudication system can review a claim, apply thousands of plan-level rules, and generate a denial in milliseconds. It doesn't get tired. It doesn't have a backlog. It fires consistently, at scale, knowing that the economics of non-response favor the payer. The response has to be upstream and systematic, not downstream and manual.
In our work building revenue cycle AI systems, the pattern is consistent. The organizations that move from reactive to proactive close three gaps simultaneously: they connect clinical documentation to financial outcomes in real time; they train models on their specific payer behavior -- not industry averages; and they ingest every clearinghouse and remittance result as training data so the model gets smarter with every claim.
That last point is where clearinghouse integrations become genuinely strategic rather than just operational. The remittance files, the CARC and RARC denial codes, the claim status responses -- all of this is rich signal data that most organizations use only to work the immediate denial. A payer-aware intelligence layer treats every one of those outcomes as a learning event. A denial from a specific Medicare Advantage plan on a specific procedure code should immediately update the model's prediction for every future claim with similar characteristics. Over time, the organization knows its payers' denial behavior better than its payers expect.
The payvider shift: making clinical workflows payer-aware
There's a term becoming increasingly relevant in value-based care: payvider. It describes organizations that function as both payer and provider. But the concept applies more broadly. Any provider operating in a value-based or risk-based contract needs to understand the payer perspective from the inside -- what their patient population's risk profile looks like, where documentation gaps create HCC coding misses, and how prior authorization patterns vary by plan in ways that affect utilization and cost. That's not billing knowledge -- it's clinical workflow knowledge that has direct financial implications.
The question isn't whether to make clinical workflows payer-aware. In a value-based world, it's whether your providers have the information they need to make decisions that serve both the patient and the organization. Right now, most don't.
We've seen this play out directly in RAF and HCC coding work for Medicare Advantage populations. The issue isn't that clinicians are coding incorrectly -- it's that chronic conditions are documented in some encounters and not others, that medications appear without supporting diagnoses, that a patient who was an amputee last year isn't reflected as one this year because the relevant note wasn't pulled forward. When we built upstream intelligence for a multi-state Medicare Advantage population, the result was $12 million in recurring annual revenue with 98 percent clinician adoption -- because the tool made their job easier rather than harder.
$12M
Recurring annual revenue from upstream RAF/HCC coding intelligence
98%
Clinician adoption rate -- because it made their job easier
140+
Facilities where originating site fees were being missed silently
In practice: telehealth originating site fees and the cost of CMS blind spots
Through our work with NeverAlone -- a virtual care command center platform serving post-acute skilled nursing facilities -- we've seen this gap play out directly. When a SNF originates a Medicare telehealth encounter, CMS allows the facility to bill a separate originating site fee. It's not large per encounter, but across 140+ locations and thousands of monthly encounters, it's meaningful revenue that offsets the cost of virtual care delivery.
Most facilities don't bill it -- not because they're making a deliberate choice, but because keeping up with CMS policy changes is a full-time job most lean post-acute teams can't staff. CMS updated telehealth flexibilities as recently as February 2026, with significant rule changes taking effect January 1, 2028. An intelligence layer that tracks and operationalizes those updates automatically captures revenue that would otherwise be lost silently.
What this means for technology partners and tool builders
If you're building RCM tools -- clearinghouse integrations, prior auth platforms, CDI software, coding assistance tools -- the upstream opportunity is where the next generation of value will be created. The back-end RCM market is increasingly commoditized. The organizations that will build durable differentiation are the ones that can connect clinical workflow data to financial outcomes in a way that learns continuously from what the clearinghouse reports back.
Building that capability requires production experience with EHR integrations that don't disrupt clinical flow, clearinghouse data pipelines that treat remittance files as training data, and models specific enough to be actionable at the plan level. The tools that win will be the ones that make providers proactive, not just more efficient at being reactive.